Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer.
Sartore-Bianchi A, Di Nicolantonio F, Nichelatti M, Molinari F, De Dosso S, Saletti P, Martini M, Cipani T, Marrapese G, Mazzucchelli L, Lamba S, Veronese S, Frattini M, Bardelli A, Siena S.
Sartore-Bianchi A, et al. Among authors: de dosso s.
PLoS One. 2009 Oct 2;4(10):e7287. doi: 10.1371/journal.pone.0007287.
PLoS One. 2009.
PMID: 19806185
Free PMC article.